State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines (Q34045119)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines |
scientific article |
Statements
State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines (English)
Martin G Pomper
Charlene M Dawidczyk
Chloe Kim